Q2 2026 Management View Brian Tyler, CEO, reported "strong second quarter results, which reflect sustained momentum in our ...

McKesson (MCK) delivered earnings and revenue surprises of +10.54% and -1.45%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

McKesson Corp (MCK) reports a 10% revenue increase and raises earnings guidance, despite challenges in the medical surgical ...

Drug distributor McKesson raised its fiscal 2026 profit forecast on Wednesday, betting on strong growth in its oncology and ...

McKesson again raised its adjusted profit outlook for the year after revenue rose 10% in the second quarter, boosted by higher prescription volumes and growth in distribution of oncology and ...

McKesson is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With over $300 billion in sales, the firm supplies roughly a third of the domestic ...

Quarterly Revenue Growth of 13% to ~$68 Million Gross Margin Increased to 43% on Improved Execution and Operational EfficiencyBest-in-Class ...

Cardinal Health, Inc. offers a compelling buy with strong gross profit, net income growth and robust free cash flow. Learn ...

For the quarter ended September 2025, McKesson (MCK) reported revenue of $103.15 billion, up 10.1% over the same period last year. EPS came in at $9.86, compared to $7.07 in the year-ago quarter. The ...

Swedish medical equipment maker Getinge reported on Tuesday a larger than expected drop in quarterly profit due to shortages of materials and higher component costs, sending its shares down 14% in ...